Medici List crest

Legato Merger Corp. IV

CIK: 20874501 Annual ReportLatest: 2026-11-13
Revenue: N/ANet Income: $4,202,267Source 10-K
Disclaimer: AI-assisted summary of SEC Form 10-K filings. Not official company content and not investment, legal, accounting, or tax advice. See full disclaimer here.

10-K / November 13, 2026

Not Specified

Company at a glance

  • Legal form: Cayman Islands exempted company; blank-check company (SPAC).
  • Inception: Incorporated September 1, 2025.
  • Purpose: Identify and complete a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses or entities.
  • Industry focus (current intent, not exclusive): Infrastructure, industrial, artificial intelligence, and technology.
  • Headquarters: 777 Third Avenue, 37th Floor, New York, NY 10017.
  • G&A arrangement: Crescendo Advisors II, LLC (affiliated with Mr. Rosenfeld) provides general and administrative services; headquarters costs are included in a $25,000 per-month fee.

Financing and capitalization

  • IPO (consummated January 26, 2026):
    • Units issued: 23,000,000 units (includes 3,000,000 units from the underwriters’ over-allotment option, exercised in full).
    • Offering price: $10.00 per unit.
    • Gross proceeds from IPO: $230,000,000.
    • Unit composition: 1 ordinary share + 1/3 of a redeemable warrant.
    • Warrant exercise price: $11.50 per share.
  • Private placement (simultaneous with IPO):
    • Units: 550,000 units at $10.00 per unit.
    • Proceeds: $5,500,000.
    • Each unit: 1 ordinary share + 1/3 of a warrant.
  • Warrants outstanding:
    • Public warrants: 7,666,667 (issued with IPO units).
    • Private placement warrants: 183,333 (from Private Placement Units).
  • Authorized capital (as reported):
    • Ordinary shares: up to 200,000,000.
    • Preference shares: up to 1,000,000.
  • Post-IPO authorized but unissued ordinary shares: 160,883,333 (reserved for warrants and other issuances).
  • Trust account and use of funds:
    • IPO and private placement proceeds are held in a trust account.
    • Permitted investments: cash, U.S. government securities with short maturities, or money market funds that meet Rule 2a-7.
    • Purpose: fund an initial business combination and related redemptions; protect public shareholders’ pro rata rights to trust assets.
    • 80% fair market value test: target business(es) must have a fair market value of at least 80% of the trust account balance (net of certain offsets) at the time of the definitive agreement for the initial business combination. The board may obtain an independent valuation if needed.

Business plan and deal mechanics

  • Financing sources for a business combination: cash held in trust, proceeds from private placements, existing shares, or debt.
  • Transaction structure: May acquire 100% of a target, acquire a controlling or non-controlling stake, or structure the deal through a subsidiary; post-transaction public ownership may be diluted depending on terms.
  • Valuation: The board will determine the target’s fair market value; if it cannot independently determine value, it will seek an independent valuation opinion.
  • Shareholder approvals and redemption:
    • Public shareholders may convert their shares for a pro rata portion of trust assets (two business days before consummation) or tender shares in a cash offer where applicable.
    • Business combinations approved by ordinary resolution under Cayman Islands law require the affirmative vote of a majority of attending and voting shareholders.
    • If a transaction’s price or structure warrants a tender offer instead of a shareholder vote, the company may use a tender offer with terms similar to proxy materials.
  • Multiple deals: Management may pursue more than one target, but is more likely to complete a single business combination due to resource constraints.

Operational status

  • Operating history: No operating history to date.
  • Revenue: No operating revenues reported to date.

Employees and management

  • Current officers: Four executive officers.
  • Staffing plan: No full-time employees anticipated prior to completing a business combination.
  • Time commitment and conflicts: Officers and directors are not contractually obligated to devote fixed hours and will allocate time as needed; outside commitments and existing fiduciary duties could create conflicts of interest.

Key financial and risk highlights

  • No revenues or operating activities to date.
  • Material risks include failure to complete a business combination, potential liquidation, and the need to raise additional funds if necessary.
  • Trust funds may be subject to third-party claims; any indemnity from Crescendo Advisors LLC is not guaranteed to cover all claims.
  • Potential dilution from issuing additional shares or equity-linked securities in connection with a future business combination.
  • Warrant terms may cause dilution or be adjusted; redemption of warrants could render them worthless or reduce upside.
  • Complex regulatory and tax considerations (including PFIC risk, potential U.S. excise tax in certain circumstances, Cayman Islands governance, and potential U.S. regulatory reviews such as CFIUS for U.S. targets).
  • Potential treatment as an investment company under the Investment Company Act if funds are not invested as described, which could necessitate compliance or liquidation.
  • Legal and fiduciary framework: Cayman Islands governing law and forum provisions that may limit certain forms of recourse for U.S. investors.

Governance and legal framework

  • Governing law: Cayman Islands (Companies Act provisions and Cayman common law).
  • Forum selection: An exclusive Cayman Islands forum is designated for certain disputes, with exceptions for claims under the Securities Act or Exchange Act.
  • Possible corporate actions: The company may de-register or continue to another jurisdiction as part of a business combination; such changes could have tax implications for shareholders.

Notable dates

  • IPO and over-allotment consummation: January 26, 2026.
  • Target date to complete initial business combination: January 26, 2028 (extendable to April 26, 2028 if extension conditions are satisfied).

Summary takeaway

This Cayman Islands–registered blank-check company was formed to pursue a substantial business combination, primarily in infrastructure, industrial, artificial intelligence, or technology sectors. It raised approximately $235.5 million in gross proceeds from its IPO and private placement and holds those proceeds in a trust account to fund a future acquisition and related redemptions. The company currently has four executive officers, no operating revenue, and no operating history. Key risks include finding a suitable target, potential dilution, regulatory and tax uncertainties, trust fund exposure to claims, and the possibility of liquidation if a transaction is not completed within the stated timeframe.